The healthcare institution and life-sciences technology platform are working together to use artificial intelligence to detect and understand the virus.
The company is putting artificial intelligence to work in the hopes of coming up with more precise, effective tests and therapies for a range of diseases.
The technology, developed by life-sciences software firm Deep Lens, integrates cancer genetic data into an advanced platform to connect patients with studies and treatments.
Produced by clinical trial software firm Florence Healthcare, the awards program seeks to recognize the contribution research professionals make to the industry.
The company’s global analysis from thousands of studies and sites indicates dramatic shifts in enrollment across several countries since the pandemic began.
Led by Medable, the multi-company effort is geared toward ramping up development of treatments, diagnostics and other solutions for the pandemic-causing virus.
The health data specialists look at real-world evidence and real-world data, and how clinical trial sites and sponsors can make the best use of such information tools.
A report by Science 37 examines key considerations for patient safety and business continuity in the clinical trial industry in light of the ongoing coronavirus pandemic.
Innovative Trials is set to work on increasing awareness within patient communities and improving engagement rates on behalf of Christie NHS Foundation Trust.
The health information technology company is looking at ways to alleviate the burdens clinical trial participants face, in order to improve recruitment and retention.
The clinical trial solutions provider has assembled a US-based network of advocates to help find ways to elevate patient access, experience and outcomes.
The company’s Goes Direct effort seeks to partner with local doctors and other community healthcare providers to encourage broader representation in clinical trials.
The latest Study Voices survey from BBK Worldwide indicates healthcare consumers and trial participants think alike towards technology, doctor access and quality of care.
US FDA’s 2019 Drugs Trials Snapshots show female participation in clinical trials of the drugs approved during the past year increased, although ethnic diversity remains an issue.
